“As colleges and universities across the country make difficult decisions to advance their vital missions this fall, the $55 billion in federal support for academic research and development (i.e., research on campus) is under threat. Maintaining the strength of the U.S. research company — the same research company that enables rapid sequencing of the COVID-19 genome and has launched numerous treatment and vaccine studies — must be a national priority,” the letter reads. It`s a dream for us. .

Did you like this? Share it!